PSYCHEMEDICS CORP (PMD) Stock Fundamental Analysis

NASDAQ:PMD • US7443752057

2.67 USD
-0.05 (-1.84%)
At close: Dec 12, 2024
2.36 USD
-0.31 (-11.61%)
After Hours: 12/12/2024, 8:24:41 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, PMD scores 2 out of 10 in our fundamental rating. PMD was compared to 102 industry peers in the Health Care Providers & Services industry. While PMD seems to be doing ok healthwise, there are quite some concerns on its profitability. PMD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • PMD had negative earnings in the past year.
  • In the past year PMD had a positive cash flow from operations.
  • PMD had negative earnings in 4 of the past 5 years.
  • In multiple years PMD reported negative operating cash flow during the last 5 years.
PMD Yearly Net Income VS EBIT VS OCF VS FCFPMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -30.45%, PMD is doing worse than 84.26% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -54.99%, PMD is doing worse than 69.44% of the companies in the same industry.
Industry RankSector Rank
ROA -30.45%
ROE -54.99%
ROIC N/A
ROA(3y)-14.19%
ROA(5y)-10.61%
ROE(3y)-25.92%
ROE(5y)-19.89%
ROIC(3y)N/A
ROIC(5y)N/A
PMD Yearly ROA, ROE, ROICPMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

1.3 Margins

  • PMD has a better Gross Margin (38.36%) than 64.81% of its industry peers.
  • PMD's Gross Margin has declined in the last couple of years.
  • PMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.48%
GM growth 5Y-4.66%
PMD Yearly Profit, Operating, Gross MarginsPMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • PMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for PMD has been increased compared to 1 year ago.
  • PMD has a better debt/assets ratio than last year.
PMD Yearly Shares OutstandingPMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
PMD Yearly Total Debt VS Total AssetsPMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

  • Based on the Altman-Z score of 0.82, we must say that PMD is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.82, PMD is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of PMD is 1.21, which is an excellent value as it means it would take PMD, only 1.21 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.21, PMD belongs to the top of the industry, outperforming 89.81% of the companies in the same industry.
  • A Debt/Equity ratio of 0.09 indicates that PMD is not too dependend on debt financing.
  • PMD's Debt to Equity ratio of 0.09 is fine compared to the rest of the industry. PMD outperforms 74.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.21
Altman-Z 0.82
ROIC/WACCN/A
WACC9.04%
PMD Yearly LT Debt VS Equity VS FCFPMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

  • PMD has a Current Ratio of 1.59. This is a normal value and indicates that PMD is financially healthy and should not expect problems in meeting its short term obligations.
  • PMD has a Current ratio of 1.59. This is in the better half of the industry: PMD outperforms 60.19% of its industry peers.
  • PMD has a Quick Ratio of 1.59. This is a normal value and indicates that PMD is financially healthy and should not expect problems in meeting its short term obligations.
  • PMD has a Quick ratio of 1.59. This is in the better half of the industry: PMD outperforms 62.04% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
PMD Yearly Current Assets VS Current LiabilitesPMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.38% over the past year.
  • Looking at the last year, PMD shows a very negative growth in Revenue. The Revenue has decreased by -11.15% in the last year.
  • The Revenue for PMD have been decreasing by -12.33% on average. This is quite bad
EPS 1Y (TTM)24.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.79%
Revenue 1Y (TTM)-11.15%
Revenue growth 3Y1.14%
Revenue growth 5Y-12.33%
Sales Q2Q%-9.21%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMD Yearly Revenue VS EstimatesPMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PMD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PMD Price Earnings VS Forward Price EarningsPMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, PMD is valued a bit cheaper than 65.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.63
EV/EBITDA N/A
PMD Per share dataPMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • PMD has a Yearly Dividend Yield of 12.67%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.48, PMD pays a better dividend. On top of this PMD pays more dividend than 99.07% of the companies listed in the same industry.
  • PMD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 12.67%

5.2 History

  • The dividend of PMD decreases each year by -27.43%.
  • PMD has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-27.43%
Div Incr Years0
Div Non Decr Years0
PMD Yearly Dividends per sharePMD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 0.2 0.4 0.6

5.3 Sustainability

  • PMD pays out 0.03% of its income as dividend. This is a sustainable payout ratio.
DP0.03%
EPS Next 2YN/A
EPS Next 3YN/A
PMD Yearly Income VS Free CF VS DividendPMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M
PMD Dividend Payout.PMD Dividend Payout, showing the Payout Ratio.PMD Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

PSYCHEMEDICS CORP

NASDAQ:PMD (12/12/2024, 8:24:41 PM)

After market: 2.36 -0.31 (-11.61%)

2.67

-0.05 (-1.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07
Earnings (Next)N/A
Inst Owners20.49%
Inst Owner Change0%
Ins Owners12.5%
Ins Owner Change0%
Market Cap15.73M
Revenue(TTM)20.26M
Net Income(TTM)-3.00M
Analysts100
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 12.67%
Yearly Dividend0.14
Dividend Growth(5Y)-27.43%
DP0.03%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.78
P/FCF 32.63
P/OCF 27.59
P/B 2.89
P/tB 2.89
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.08
FCFY3.06%
OCF(TTM)0.1
OCFY3.62%
SpS3.44
BVpS0.92
TBVpS0.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.45%
ROE -54.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.36%
FCFM 2.38%
ROA(3y)-14.19%
ROA(5y)-10.61%
ROE(3y)-25.92%
ROE(5y)-19.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.48%
GM growth 5Y-4.66%
F-Score5
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.21
Debt/EBITDA N/A
Cap/Depr 6.99%
Cap/Sales 0.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z 0.82
F-Score5
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)7.85%
Cap/Depr(5y)23.62%
Cap/Sales(3y)0.73%
Cap/Sales(5y)2.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.15%
Revenue growth 3Y1.14%
Revenue growth 5Y-12.33%
Sales Q2Q%-9.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-85.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.99%
OCF growth 3YN/A
OCF growth 5YN/A

PSYCHEMEDICS CORP / PMD FAQ

What is the fundamental rating for PMD stock?

ChartMill assigns a fundamental rating of 2 / 10 to PMD.


What is the valuation status of PSYCHEMEDICS CORP (PMD) stock?

ChartMill assigns a valuation rating of 1 / 10 to PSYCHEMEDICS CORP (PMD). This can be considered as Overvalued.


How profitable is PSYCHEMEDICS CORP (PMD) stock?

PSYCHEMEDICS CORP (PMD) has a profitability rating of 1 / 10.


How sustainable is the dividend of PSYCHEMEDICS CORP (PMD) stock?

The dividend rating of PSYCHEMEDICS CORP (PMD) is 6 / 10 and the dividend payout ratio is 0.03%.